Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant

Por Pham, Aaron N., Bubalo, Joseph S., Lewis, James S.
Publicado no Antimicrob Agents Chemother (2016)

Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center

Por Kowalewska, Christina A, Tallman, Gregory B, Pham, Aaron N, Lewis, James S
Publicado no Open Forum Infect Dis (2017)